Multidrug-resistant infection in lung transplant recipients: risk factors and prognosis.

Infectious complication is an important cause of poor outcome of lung transplantation (LT). Infections with () are problematic, because of limited therapeutic option due to increasing resistance to antibiotics. However, there are few studies on infection in lung transplant recipients.

Outcomes of perioperative extracorporeal membrane oxygenation use in patients undergoing lung transplantation.

Background: The aim of this single-center study is to review the transplant outcomes of patients receiving lung transplantation (LTx) using intraoperative extracorporeal membrane oxygenation (ECMO) according to the perioperative use of ECMO.

Methods: We retrospectively reviewed the transplant outcomes of 107 consecutive patients who underwent LTx using intraoperative ECMO between March 2013 and August 2016 at Severance Hospital of Yonsei University (Seoul, Korea).

Results: Patients were divided into the following three groups according to the use of perioperative ECMO: only intraoperative ECMO (n=47) or extended post-operative ECMO but no bridging and no postoperative ECMO re-implantation (secondary ECMO; n=28) as Group A (n=75); bridging ECMO without secondary ECMO (n=14) as Group B; and secondary ECMO with (n=7) or without (n=11) bridging as Group C.

Risk Factor Analysis for Intraoperative Extracorporeal Membrane Oxygenation Weaning Failure After Lung Transplantation.

Background: Extracorporeal membrane oxygenation (ECMO) has been widely used for hemodynamic support during lung transplantation (LTx). We evaluated the risk factors associated with failure of weaning from ECMO in the operating room during LTx.

Methods: We retrospectively reviewed 74 consecutive patients who had undergone LTx from March 2013 to February 2016.